Topic:

April 2024

NATIONAL ADVISORY COMMITTEE OF IMMUNIZATION (NACI) RAPID RESPONSE: ADDITIONAL DOSE OF COVID-19 VACCINE IN IMMUNOCOMPROMISED INDIVIDUALS FOLLOWING 1- OR 2- DOSE PRIMARY SERIES

Please visit https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html for details.

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Lupus Treatment and Access Across Provinces: Take the Patient Survey

Advocacy & SupportNews & Events
Article
Read

Canada Disability Benefit Regulations Finalized | What It Means for Lupus Patients

Advocacy & SupportNews & Events
Article
Read

Support Lupus Awareness – Step Out for Lupus Walk 2025 Calgary

Advocacy & SupportAwareness & Community
Article
Read